Literature DB >> 20031127

Changes in cytokine levels during acute hyperinsulinemia in offspring of type 2 diabetic subjects.

Eija Ruotsalainen1, Alena Stancáková, Ilkka Vauhkonen, Urpu Salmenniemi, Jussi Pihlajamäki, Kari Punnonen, Markku Laakso.   

Abstract

OBJECTIVE: To investigate the changes in the levels of cytokines and adhesion molecules in response to acute hyperinsulinemia in the offspring of type 2 diabetic subjects.
METHODS: Forty healthy offspring of type 2 diabetic subjects and 19 control offspring of healthy parents were included in the study. Twenty offspring had normal glucose tolerance (NGT) and twenty offspring impaired glucose tolerance (IGT). Insulin sensitivity was determined by the hyperinsulinemic euglycemic clamp and insulin secretion with the intravenous glucose tolerance test. The levels of cytokines and adhesion molecules were measured before and at the end of the clamp.
RESULTS: Acute hyperinsulinemia induced by the euglycemic hyperinsulinemic clamp reduced the levels of TNF-alpha, IL-8, IL-10 and IL-18 in healthy controls but not in the offspring of type 2 diabetic subjects having NGT or IGT. In response to insulin, levels of hs-CRP decreased and levels of IL-6 increased significantly in all study groups. The levels of adhesion molecules (ICAM-1, VCAM-1, E-Selectin) remained unchanged in response to hyperinsulinemia.
CONCLUSIONS: The suppression of cytokine levels (particularly proinflammatory cytokines) during acute hyperinsulinemia observed in healthy controls was not present in offspring of type 2 diabetic patients. This emphasizes the crucial role of low-grade inflammation in insulin resistance in subjects with high risk of developing diabetes. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031127     DOI: 10.1016/j.atherosclerosis.2009.11.036

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy.

Authors:  Rodrigo M C Pestana; Caroline P Domingueti; Rita C F Duarte; Rodrigo B Fóscolo; Janice S Reis; Ana Maria S Rodrigues; Laís B Martins; Lirlândia P Sousa; Daniela P Lage; Cláudia N Ferreira; Adaliene V M Ferreira; Ana P Fernandes; Karina B Gomes
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

Review 2.  IL-6 in diabetes and cardiovascular complications.

Authors:  Dan Qu; Jian Liu; Chi Wai Lau; Yu Huang
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis.

Authors:  Xiongfeng Pan; Atipatsa C Kaminga; Shi Wu Wen; Aizhong Liu
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

4.  Circulating Monocyte and Lymphocyte Populations in Healthy First-Degree Relatives of Type 2 Diabetic Patients at Fasting and during Short-Term Hyperinsulinemia.

Authors:  Michaela Šiklová; Eva Krauzová; Barbora Svobodová; Jana Kračmerová; Marek Štěpán; Michal Koc; Vladimír Štich; Lenka Rossmeislová
Journal:  Mediators Inflamm       Date:  2019-03-11       Impact factor: 4.711

5.  Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin.

Authors:  B Lindegaard; S Ditlevsen; P Plomgaard; B Mittendorfer; B K Pedersen
Journal:  Diabetologia       Date:  2013-06-29       Impact factor: 10.122

6.  Effects of Glucose Ingestion on Serum Fractalkine Levels in Healthy Subjects and Newly Diagnosed Type 2 Diabetic Patients.

Authors:  Suleyman Baldane; Ismail Can Kendir; Cem Onur Kirac; Suleyman Ipekci; Gulsum Tekin; Ali Unlu; Levent Kebapcilar
Journal:  J Med Biochem       Date:  2018-07-01       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.